Piperine

Piperine at a Glance

Piperine is the pungent alkaloid of black pepper (Piper nigrum) — the piperidine amide that gives peppercorns their bite, the counterpart to chilli’s capsaicin. It is the plant’s principal alkaloid, making up roughly 2–9% of the dried fruit ^{4,5Reference 4Takooree H et al. · 2019Systematic reviewA systematic review on black pepper (Piper nigrum L.): from folk uses to pharmacological applicationsView study →Reference 5Srinivasan K · 2007ReviewBlack pepper and its pungent principle-piperine: a review of diverse physiological effectsView study →}.

Its fame, though, rests on something other than its own pharmacology: piperine is the best-known natural bioavailability enhancer. By inhibiting the drug-metabolising enzyme CYP3A4, the efflux transporter P-glycoprotein, and phase-II glucuronidation, it slows the breakdown and export of co-administered compounds so that more reaches the bloodstream. The signature result is the curcumin pairing — a single human study reported a 2000% (twentyfold) increase in curcumin absorption when piperine was added ^{1Reference 1Shoba G et al. · 1998Clinical trialInfluence of piperine on the pharmacokinetics of curcumin in animals and human volunteersView study →}. This is why a few milligrams of piperine (often as the branded extract BioPerine) appear in so many turmeric and nootropic formulas ^{6Reference 6Haq IU et al. · 2021ReviewPiperine: A review of its biological effectsView study →}.

That same enhancing mechanism is the honest caution here: an enzyme-and-transporter inhibitor does not discriminate between a supplement and a prescription drug, so concentrated piperine can raise the levels — and the risk — of real medications ^{2,15Reference 2Bhardwaj RK et al. · 2002Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4View study →Reference 15Ziegenhagen R et al. · 2021Safety aspects of the use of isolated piperine ingested as a bolusView study →}. Beyond the enhancer role, piperine carries a broad preclinical profile (anti-inflammatory, antioxidant, metabolic, neuroprotective) that is almost entirely animal and in-vitro work.

Piperine as a Bioavailability Enhancer

This is the load-bearing section of the page — the property piperine is actually used for, and the one with genuine human data.

The mechanism is multi-pronged. Piperine slows the body’s clearance of other molecules through at least three routes acting together:

• CYP3A4 inhibition — it inhibits the major intestinal/hepatic drug-metabolising enzyme, so first-pass oxidation of a co-administered compound falls ^{2Reference 2Bhardwaj RK et al. · 2002Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4View study →}.
• P-glycoprotein (P-gp) inhibition — it blocks the intestinal efflux pump that would otherwise pump absorbed molecules back into the gut lumen; in Caco-2 cells piperine inhibited P-gp-mediated transport of digoxin and cyclosporine A (IC50 ≈ 15.5 and 74.1 µM) ^{2Reference 2Bhardwaj RK et al. · 2002Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4View study →}.
• Glucuronidation / sulfation down-regulation — it inhibits UDP-glucuronosyltransferase (UGT) and aryl-hydrocarbon-hydroxylase activity and, in rats, selectively reduces UGT and SULT expression, cutting the phase-II conjugation that normally inactivates compounds like curcumin ^{3,5Reference 3Zeng X et al. · 2017AnimalSelective reduction in the expression of UGTs and SULTs, a novel mechanism by which piperine enhances the bioavailability of curcumin in ratView study →Reference 5Srinivasan K · 2007ReviewBlack pepper and its pungent principle-piperine: a review of diverse physiological effectsView study →}.

The curcumin result is the headline. In the study that launched the pairing, Shoba and colleagues gave curcumin with and without 20 mg piperine: bioavailability rose 154% in rats and, strikingly, 2000% in human volunteers — a twentyfold jump — with no reported adverse effect at that dose ^{1Reference 1Shoba G et al. · 1998Clinical trialInfluence of piperine on the pharmacokinetics of curcumin in animals and human volunteersView study →}. Curcumin is notoriously poorly absorbed and rapidly glucuronidated, so blocking that conjugation step has an outsized effect. The mechanism was later pinned to the selective suppression of curcumin-metabolising UGTs and SULTs ^{3Reference 3Zeng X et al. · 2017AnimalSelective reduction in the expression of UGTs and SULTs, a novel mechanism by which piperine enhances the bioavailability of curcumin in ratView study →}. It is worth holding the scope: this rests substantially on one small human pharmacokinetic study, and enhanced absorption is not itself a clinical outcome.

The flip side is a real drug interaction. The property that makes piperine useful with curcumin makes it a genuine caution with medication. Because CYP3A4 and P-gp handle a large share of prescription drugs, piperine can raise their plasma levels too. A safety review found that bolus doses of ~20 mg piperine/day increased the bioavailability of propranolol, theophylline and carbamazepine (roughly 1.1- to 2.7-fold) ^{15Reference 15Ziegenhagen R et al. · 2021Safety aspects of the use of isolated piperine ingested as a bolusView study →}. That is the same magnitude of effect, pointed at drugs with narrow margins rather than at a poorly-absorbed spice pigment — which is why concentrated piperine supplements warrant caution in anyone on regular medication. See curcumin for the partner molecule.

A note on turmeric. Piperine is not a turmeric constituent — it is black pepper’s alkaloid. Its relevance to turmeric is entirely this bioavailability-enhancer combination; do not read the pairing as piperine occurring in Curcuma longa.

The Pungency Principle

Piperine is to black pepper what capsaicin is to chilli: the pungent principle. The sharp, biting heat of pepper comes from piperine activating TRPV1, the same capsaicin/heat-sensing ion channel on sensory nerves ^{8Reference 8McNamara FN et al. · 2005Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1)View study →}.

At the receptor, piperine is a bona-fide TRPV1 agonist — and an unusual one. In the human-receptor assay it activated TRPV1 with greater efficacy than capsaicin itself, while also driving pronounced receptor desensitisation ^{8Reference 8McNamara FN et al. · 2005Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1)View study →}. Perceptually it is far milder than capsaicin, though: its pungency threshold is on the order of ~10 µM versus ~0.6 µM for capsaicin, roughly 10–100× less hot ^{9Reference 9Ursu D et al. · 2010Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicityView study →}. That gap tracks a general rule for TRPV1 agonists — perceived pungency correlates with how fast the agonist opens the channel and with its lipophilicity, and piperine is slower and less lipophilic than capsaicin ^{9Reference 9Ursu D et al. · 2010Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicityView study →}.

Structurally, piperine occurs as the all-trans (E,E) isomer; its geometric isomers (notably chavicine, the cis,cis form) share the pungent-amide skeleton but differ in taste, which is part of why processing and storage shift a pepper’s bite.

What It's Used For

Beyond the enhancer role, piperine has a wide preclinical literature — anti-inflammatory, antioxidant, metabolic, neuroprotective and anticancer signals — but the evidence tier drops sharply once you leave the bioavailability story. Almost all of it is rodent and in-vitro work on the isolated alkaloid.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Only the enhancer row carries direct human pharmacokinetic data; the rest are preclinical, so their scores stay modest by design.

01Bioavailability enhancementPromising60%Human + rat PK; defined CYP3A4/P-gp/UGT mechanism ^{1,2,3Reference 1Shoba G et al. · 1998Clinical trialInfluence of piperine on the pharmacokinetics of curcumin in animals and human volunteersView study →Reference 2Bhardwaj RK et al. · 2002Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4View study →Reference 3Zeng X et al. · 2017AnimalSelective reduction in the expression of UGTs and SULTs, a novel mechanism by which piperine enhances the bioavailability of curcumin in ratView study →}

02Anti-inflammatory / antioxidantShaky34%Rodent/cell isolate; NF-κB↓, Nrf2/HO-1↑ ^{6,7Reference 6Haq IU et al. · 2021ReviewPiperine: A review of its biological effectsView study →Reference 7Turrini E et al. · 2020Overview of the anticancer potential of the “king of spices” Piper nigrum and its main constituent piperineView study →}

03Metabolic / anti-obesityShaky30%Isolate ↓ adipogenesis (PPARγ), ↑ resting-muscle metabolic rate in mice ^{11,12Reference 11Park UH et al. · 2012Piperine, a component of black pepper, inhibits adipogenesis by antagonizing PPARγ activity in 3T3-L1 cellsView study →Reference 12Nogara L et al. · 2016Piperine’s mitigation of obesity and diabetes can be explained by its up-regulation of the metabolic rate of resting muscleView study →}

04Neuroprotective / CNSShaky28%Rodent models (Alzheimer’s, Parkinson’s); weak MAO inhibition ^{10,13,14Reference 10Kong LD et al. · 2004Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinonesView study →Reference 13Azam S et al. · 2022Piperine and its metabolite’s pharmacology in neurodegenerative and neurological diseasesView study →Reference 14Wang C et al. · 2019AnimalPiperine attenuates cognitive impairment in an experimental mouse model of sporadic Alzheimer’s diseaseView study →}

Mechanisms

The load-bearing rows are the top three: the CYP3A4 / P-gp / UGT inhibitions are simultaneously the enhancer mechanism and the drug-interaction mechanism — the same pharmacology read two ways.

Pharmacokinetics

Piperine is a lipophilic amide that is itself reasonably absorbed orally and is extensively metabolised — it is both a substrate and an inhibitor of the CYP/UGT machinery it acts on, which is why it can saturate and slow the metabolism of co-administered compounds ^{2,5Reference 2Bhardwaj RK et al. · 2002Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4View study →Reference 5Srinivasan K · 2007ReviewBlack pepper and its pungent principle-piperine: a review of diverse physiological effectsView study →}. It distributes widely and crosses the blood–brain barrier, underpinning its CNS activity ^{13Reference 13Azam S et al. · 2022Piperine and its metabolite’s pharmacology in neurodegenerative and neurological diseasesView study →}. The practical PK point specific to this molecule is inverted from the usual compound page: piperine’s value is less about its own plasma level and more about how it raises everyone else’s — its enzyme/transporter inhibition is the pharmacokinetic story. Robust human ADME figures for isolated piperine (Cmax, half-life, oral bioavailability) are not well established; most kinetic data are rodent ^{5,15Reference 5Srinivasan K · 2007ReviewBlack pepper and its pungent principle-piperine: a review of diverse physiological effectsView study →Reference 15Ziegenhagen R et al. · 2021Safety aspects of the use of isolated piperine ingested as a bolusView study →}.

Clinical Trials

Direct controlled human trials of piperine as a therapy are essentially absent; the human evidence is pharmacokinetic (piperine as an enhancer of another compound), not efficacy trials of piperine itself.

Last checked: July 2026.

Isolate vs. Plant Studies

Almost the entire piperine literature is the isolated alkaloid (or the ~95%-pure extract BioPerine), not whole black pepper — which for a compound page is a clean setup, because the thing being sold and studied is the isolate ^{6Reference 6Haq IU et al. · 2021ReviewPiperine: A review of its biological effectsView study →}. The human bioavailability and drug-interaction data used the pure compound at defined milligram doses ^{1,15Reference 1Shoba G et al. · 1998Clinical trialInfluence of piperine on the pharmacokinetics of curcumin in animals and human volunteersView study →Reference 15Ziegenhagen R et al. · 2021Safety aspects of the use of isolated piperine ingested as a bolusView study →}. The mechanistic anti-inflammatory, metabolic and neuroprotective work is likewise isolate-in-rodents ^{11,12,13Reference 11Park UH et al. · 2012Piperine, a component of black pepper, inhibits adipogenesis by antagonizing PPARγ activity in 3T3-L1 cellsView study →Reference 12Nogara L et al. · 2016Piperine’s mitigation of obesity and diabetes can be explained by its up-regulation of the metabolic rate of resting muscleView study →Reference 13Azam S et al. · 2022Piperine and its metabolite’s pharmacology in neurodegenerative and neurological diseasesView study →}. A species caveat runs alongside: piperine also occurs in long pepper (Piper longum) and other Piper species, and several hepatoprotection and alkaloid papers use P. longum material — molecule-level findings should be attributed to piperine, not specifically to P. nigrum ^{5Reference 5Srinivasan K · 2007ReviewBlack pepper and its pungent principle-piperine: a review of diverse physiological effectsView study →}. The gap is not isolate-vs-plant here so much as preclinical-vs-clinical: strong isolate mechanism, one small human PK study for the marquee claim, and no efficacy trials.

The Pungency Principle in Plants

In the black-pepper vine, piperine and its fellow pungent amides are defence and deterrent compounds — the pungency that reads as culinary “heat” to humans is, ecologically, a chemical discouragement to herbivores and microbes, the same logic as capsaicin in chillies. The alkaloid concentrates in the fruit (the peppercorn), where it protects the developing seed. Its content is not fixed: it varies with cultivar, ripeness at harvest, geographic provenance (Malabar vs. Vietnamese vs. Brazilian stock) and processing — black, white and green peppercorns are the same fruit handled differently, which shifts the balance of piperine and its isomers (and hence the bite) ^{4,5Reference 4Takooree H et al. · 2019Systematic reviewA systematic review on black pepper (Piper nigrum L.): from folk uses to pharmacological applicationsView study →Reference 5Srinivasan K · 2007ReviewBlack pepper and its pungent principle-piperine: a review of diverse physiological effectsView study →}.

Prevalence in Nature

Piperine is the principal alkaloid of black pepper (Piper nigrum), present at roughly 2–9% of the dried fruit by weight — a genuinely high content for a plant alkaloid, and the reason pepper is its commercial source ^{4,5Reference 4Takooree H et al. · 2019Systematic reviewA systematic review on black pepper (Piper nigrum L.): from folk uses to pharmacological applicationsView study →Reference 5Srinivasan K · 2007ReviewBlack pepper and its pungent principle-piperine: a review of diverse physiological effectsView study →}. The wide range reflects cultivar, ripeness, origin and processing rather than measurement noise ^{4Reference 4Takooree H et al. · 2019Systematic reviewA systematic review on black pepper (Piper nigrum L.): from folk uses to pharmacological applicationsView study →}.

It is not confined to P. nigrum. Piperine also occurs in long pepper (Piper longum) and various other Piper species, where it co-occurs with related pungent amides such as piperlongumine (characteristic of P. longum, not black pepper). Within black pepper itself it sits alongside minor pungent isomers and amides — chavicine, piperettine and piperanine — that share its piperidine-amide class and contribute to the spice’s overall pungency ^{5Reference 5Srinivasan K · 2007ReviewBlack pepper and its pungent principle-piperine: a review of diverse physiological effectsView study →}.

Discovery & Synthesis

Piperine was first isolated in 1819 by the Danish physicist-chemist Hans Christian Ørsted, who obtained it as a yellow crystalline solid from black-pepper fruit — one of the earlier plant alkaloids to be purified, and the discovery that identified the chemical source of pepper’s pungency. Its structure was settled by synthesis later in the century: Leopold Rügheimer reported the first synthesis in 1882 (“Künstliches Piperin”), condensing piperoyl chloride with piperidine, and Ladenburg and Scholtz completed a full synthesis from piperonal in 1894 — establishing piperine as the piperidine amide of piperic acid, i.e. 1-piperoylpiperidine.

Manufacture today is still overwhelmingly extraction from black pepper, since the natural material is cheap and rich (2–9% piperine); the standardised supplement ingredient BioPerine is a pepper extract concentrated to ~95% piperine rather than a synthetic product. Total synthesis exists and is straightforward but is not the commercial route.

Patents: not yet researched.

Toxicity & Safety

Piperine carries a moderate flag. As a component of one of the world’s most-eaten spices it is low-toxicity at ordinary dietary levels — but this molecule page is about the isolated alkaloid in concentrated supplement form, where its defining property is precisely a mechanism that alters the handling of other substances. That, plus animal reproductive findings, is why it sits above a bland “low.”

Safety at a Glance

⚠️ Moderate toxicityDrug interactions

• Low toxicity at dietary levels. A normal constituent of a common spice, with a long history of food use and no genotoxicity signal at culinary intake ^{5Reference 5Srinivasan K · 2007ReviewBlack pepper and its pungent principle-piperine: a review of diverse physiological effectsView study →}.
• Drug-interaction risk — the main practical caution. By inhibiting CYP3A4, P-glycoprotein and glucuronidation, concentrated piperine can raise the plasma levels of medications; ~20 mg/day increased propranolol, theophylline and carbamazepine exposure. Anyone on regular medication should treat piperine/BioPerine supplements as a potential interactant ^{2,15Reference 2Bhardwaj RK et al. · 2002Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4View study →Reference 15Ziegenhagen R et al. · 2021Safety aspects of the use of isolated piperine ingested as a bolusView study →}.
• The enhancer effect is not selective. The same milligram doses that boost curcumin can boost a drug with a narrow therapeutic margin — the benefit and the hazard are one mechanism ^{1,15Reference 1Shoba G et al. · 1998Clinical trialInfluence of piperine on the pharmacokinetics of curcumin in animals and human volunteersView study →Reference 15Ziegenhagen R et al. · 2021Safety aspects of the use of isolated piperine ingested as a bolusView study →}.
• Animal reproductive findings. In rodents, ~10 mg/kg/day disturbed spermatogenesis and marked the lowest adverse-effect level for maternal/embryotoxic effects — a reason to be cautious with high-dose isolates ^{15Reference 15Ziegenhagen R et al. · 2021Safety aspects of the use of isolated piperine ingested as a bolusView study →}.

Pregnancy/lactation decisions belong to the herb or product page where intake is actually decided, not to this molecule page; the animal reproductive findings above are stated as cited risk signals, not a verdict. No comprehensive human safety dataset for isolated piperine as a bolus supplement is established ^{15Reference 15Ziegenhagen R et al. · 2021Safety aspects of the use of isolated piperine ingested as a bolusView study →}.

Dosage

There is no therapeutic dose of piperine itself — it is not used as a stand-alone remedy. Its real-world “dose” is as a bioavailability enhancer, added in small amounts to a target compound:

These are formulation and research figures, not a personal recommendation — and because piperine at these very doses can alter drug levels, the enhancer amount that helps a supplement is also the amount that can interact with medication ^{15Reference 15Ziegenhagen R et al. · 2021Safety aspects of the use of isolated piperine ingested as a bolusView study →}.

References

1. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/9619120/
2. Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF (2002). Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. Journal of Pharmacology and Experimental Therapeutics. https://pubmed.ncbi.nlm.nih.gov/12130727/
3. Zeng X, et al. (2017). Selective reduction in the expression of UGTs and SULTs, a novel mechanism by which piperine enhances the bioavailability of curcumin in rat. Biopharmaceutics & Drug Disposition. https://pubmed.ncbi.nlm.nih.gov/27882569/
4. Takooree H, et al. (2019). A systematic review on black pepper (Piper nigrum L.): from folk uses to pharmacological applications. Critical Reviews in Food Science and Nutrition. https://pubmed.ncbi.nlm.nih.gov/30740986/
5. Srinivasan K (2007). Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Critical Reviews in Food Science and Nutrition. https://pubmed.ncbi.nlm.nih.gov/17987447/
6. Haq IU, et al. (2021). Piperine: A review of its biological effects. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/32929825/
7. Turrini E, et al. (2020). Overview of the anticancer potential of the “king of spices” Piper nigrum and its main constituent piperine. Toxins. https://pubmed.ncbi.nlm.nih.gov/33256185/
8. McNamara FN, Randall A, Gunthorpe MJ (2005). Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1). British Journal of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/15685214/
9. Ursu D, Knopp K, Beattie RE, et al. (2010). Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicity. European Journal of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/20576527/
10. Kong LD, Cheng CHK, Tan RX (2004). Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/15120460/
11. Park UH, et al. (2012). Piperine, a component of black pepper, inhibits adipogenesis by antagonizing PPARγ activity in 3T3-L1 cells. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/22463744/
12. Nogara L, Naber N, Pate E, et al. (2016). Piperine’s mitigation of obesity and diabetes can be explained by its up-regulation of the metabolic rate of resting muscle. Proceedings of the National Academy of Sciences. https://pubmed.ncbi.nlm.nih.gov/27799519/
13. Azam S, Park JY, Kim IS, Choi DK (2022). Piperine and its metabolite’s pharmacology in neurodegenerative and neurological diseases. Biomedicines. https://pubmed.ncbi.nlm.nih.gov/35052833/
14. Wang C, et al. (2019). Piperine attenuates cognitive impairment in an experimental mouse model of sporadic Alzheimer’s disease. The Journal of Nutritional Biochemistry. https://pubmed.ncbi.nlm.nih.gov/31207354/
15. Ziegenhagen R, Heimberg K, Lampen A, Hirsch-Ernst KI (2021). Safety aspects of the use of isolated piperine ingested as a bolus. Foods. https://pubmed.ncbi.nlm.nih.gov/34574230/

View all 15 references▾